Immunohaematology blood grouping antisera IVDs

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

下载 公众评估报告 (PAR)
06-11-2017

可用日期:

Grifols Australia Pty Ltd

类:

Class 3

厂商:

Antitoxin GmbH Industriestrasse 88, Bammental, 69245 Germany

治疗领域:

CT887 - Immunohaematology blood grouping antisera IVDs

疗效迹象:

Immunoglobulins capable of binding to specific red blood cell antigens and intended to be used in immunohaematological testing to provide information about red blood cell antigen phenotypes.

授权状态:

A

授权日期:

2015-11-05

搜索与此产品相关的警报